Sarepta stock may recover sharply as additional information and data reveal that the adverse event reported by the company is ...

Among these, Sarepta Therapeutics crashed following a report of a patient's death after treatment with Elevidys. Incyte also declined after study data disappointed investors. Shares of Sarepta ...

A new Oregon Health & Science University and Weill Cornell Medicine co-authored study provides critical insight for the ...

A new Weill Cornell Medicine and Oregon Health & Science University co-authored study provides critical insight for the development of a vaccine that can more effectively block the spread of ...

Shares of biotech company Sarepta Therapeutics (NASDAQ:SRPT) fell 24.9% in the pre-market session after the company reported ...

Hurricanes’ Shane Smith pledges $25 per point to CMV Foundation in honor of his niece, raising awareness for a cause close to his heart.

CMV or cytomegalovirus is a common virus that is spread through body fluids such as saliva, tears, blood, urine, breast milk, semen, and vaginal fluids. Once you are infected with CMV, you are ...

After Sarepta reported the death of a patient who had recently taken the gene therapy Elevydis, patient advocacy group Parent ...

The patient, whom Sarepta described as a young man and later told news outlets was 16 years old, suffered acute liver failure ...